National Bank of Canada’s CureVac CVAC Stock Holding History

National Bank of Canada’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-327	Closed	-$176K	–	2940
2025 Q3	$176K	Sell	327 -3,623	-92%	-$19.6K	﹤0.01%	1602
2025 Q2	$2.14M	Buy	+3,950	New	+$15.7K	﹤0.01%	1130

Other funds holding CVAC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

National Bank of Canada's CVAC Position: Q4 2025 in Review

National Bank of Canada sold out of CureVac (CVAC) in Q4 2025, closing a stake of 7,160 shares — an estimated $38.6K sold.

National Bank of Canada first reported a position in CVAC in Q4 2021 and held it in 16 quarters. The position peaked at $1.41M in Q2 2025. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

National Bank of Canada reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
National Bank of Canada sold 7,160 CureVac shares in Q4 2025, an estimated $38.6K.
National Bank of Canada first reported a position in CureVac in Q4 2021 and held it in 16 quarters.
National Bank of Canada's CureVac position peaked at $1.41M in Q2 2025.
57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on National Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.